Helga Kleiner

Mannheim, BW 68167, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR.

Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR.

Journal: Cancers
Published: July 03, 2023

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML.

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML.

Journal: Cancers
Published: April 17, 2023

Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.

Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.

Journal: Cancers
Published: April 30, 2022

Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10-100 kDa Fraction of Conditioned Medium.

Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10-100 kDa Fraction of Conditioned Medium.

Journal: Cells
Published: March 23, 2021

Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells.

Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells.

Journal: International journal of molecular sciences
Published: March 14, 2021

DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia.

DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia.

Journal: International journal of molecular sciences
Published: November 26, 2019

Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients.

Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients.

Journal: Annals of hematology
Published: September 30, 2019

Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.

Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.

Journal: Cancers
Published: August 18, 2019

Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: November 01, 2018

Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.

Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.

Journal: PloS one
Published: August 30, 2017

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.

Journal: Biomarker research
Published: December 01, 2015

Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.

Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.

Journal: PloS one
Published: March 05, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026